Correspondence 0001193125-23-255099 from Lite Strategy, Inc. (LITS)
Lite Strategy, Inc.
Date: Oct. 12, 2023 · CIK: 0001262104 · Accession: 0001193125-23-255099
AI Filing Summary & Sentiment
File numbers found in text: 000-50484
Show Raw Text
CORRESP 1 filename1.htm CORRESP Justin W. Chairman +1.215.963.5061 justin.chairman@morganlewis.com October 12, 2023 Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Attention: Perry Hindin, Esquire Re: MEI Pharma, Inc. Preliminary Consent Revocation Statement on Schedule 14A filed September 15, 2023 File No. 000-50484 To Whom it May Concern: On behalf of MEI Pharma, Inc. (the “Company”), we submit this letter to notify the Staff of the Company’s filing of a revised Preliminary Consent Revocation Statement on Schedule 14A. This filing is being made in response to the filing on October 10, 2023, by Cable Car Capital LLC, Anson Advisors Inc. and the other participants named therein, of a Definitive Consent Statement on Schedule 14A. * * * * If you have any questions or comments or require any additional information, please do not hesitate to contact me at +1.215.963.5061 or Bryan S. Keighery at +1.617.341.7269. Very truly yours, /s/ Justin W. Chairman cc: David M. Urso Morgan, Lewis & Bockius LLP 1701 Market St. Philadelphia, PA 19103-2921 United States +1.215.963.5000 +1.215.963.5001